Movantik (naloxegol)

pCPA File Number: 23415

Negotiation Status:

Active Negotiation

Indication(s):

Treatment of opioid-induced constipation (OIC) in adult patients with cancer and non-cancer pain who have had an inadequate response to laxative(s).

Sponsor/Manufacturer:

Knight Therapeutics Inc.

CDA-AMC Project Number:

SX0753-000

pCPA Engagement Letter Issued:

2026-01-13

Negotiation Process Concluded:

Not Applicable